J&J reaches $230 million opioid settlement with New York state

This post was originally published on this site

The agreement addresses claims brought by Attorney General Letitia James, and will remove Johnson & Johnson as a defendant in a broader trial over opioids scheduled to begin next week.

J&J did not admit liability or wrongdoing in agreeing to settle. It said the agreement was consistent with its prior agreement to pay $5 billion to settle opioid claims by states, cities, counties and tribal governments nationwide.